Search

The US Food and Drug Administration (FDA) is reminding health care providers that tests to detect rupture of the amniotic membranes should not be...

Sources:
  • Food and Drug Administration
Relevant To:
  • Medical Office,
  • Critical Access Hospitals,
  • Hospitals,
  • Ambulatory Care

The Centers for Medicare and Medicaid Services (CMS) has issued a Survey and Certification Memorandum to communicate an update about their work o...

Sources:
  • The Joint Commission,
  • Centers for Medicare and Medicaid Services
Relevant To:
  • Critical Access Hospitals,
  • Hospitals,
  • Community Mental Health Centers,
  • Behavioral Health

The US Centers for Medicare and Medicaid Services (CMS) has provided clarification regarding the operation of multiple laboratories at the same ...

Sources:
  • Centers for Medicare and Medicaid Services
Relevant To:
  • Clinical Lab

The Department of Labor's Occupational Safety and Health Administration (OSHA) has issued a Notice of Proposed Rulemaking (NPRM) to better protec...

Sources:
  • Occupational Safety and Health Administration
Relevant To:
  • All Healthcare Organizations

Tianeptine (marketed as Coaxil or Stablon) is an atypical tricyclic drug used an antidepressant drug in Europe, Asia, and Latin America. In the U...

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • All Healthcare Organizations

The U.S. Food and Drug Administration (FDA) is warning health care providers that the antibiotic Zithromax, Zmax (azithromycin,) should not be gi...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The Joint Commission (TJC) has made available a new patient safety resource in the form of a case example that provides a step-by-step case of an...

Sources:
  • The Joint Commission
Relevant To:
  • Critical Access Hospitals,
  • Hospitals

AuroMedics Pharma LLC is voluntarily recalling two lots of Piperacillin and Tazobactam for injection, USP 3.375 g (Piperacillin Sodium equivalent...

Sources:
  • Food and Drug Administration
Relevant To:
  • Medical Office,
  • Critical Access Hospitals,
  • Hospitals,
  • Long Term Care,
  • Ambulatory Care,
  • Pharmacy

The Joint Commission (TJC) has announced a new Perinatal Care (PC) performance measure, PC-06 Unexpected Complications in Term Newborns, effectiv...

Sources:
  • The Joint Commission
Relevant To:
  • Critical Access Hospitals,
  • Hospitals

The U.S. Food and Drug Administration (FDA) is updating health care professionals and patients after discovering that several additional companie...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The U.S. Food and Drug Administration (FDA) is alerting patients and health care providers that the use of energy-based devices to perform vagina...

Sources:
  • Food and Drug Administration
Relevant To:
  • Medical Office,
  • Critical Access Hospitals,
  • Hospitals,
  • Ambulatory Care

Ranier’s Rx Laboratory is voluntarily recalling all sterile compounded drug products within expiry to the hospital or consumer level. &...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The U.S. Food and Drug Administration (FDA) recently announced the approval of TPOXX, the first drug with an indication for treatment of Smallpox...

Sources:
  • Food and Drug Administration
Relevant To:
  • Critical Access Hospitals,
  • Hospitals,
  • Pharmacy

The Joint Commission is seeking input from the field on proposed revisions to their pain assessment and management standards within the Nursing C...

Sources:
  • The Joint Commission
Relevant To:
  • Long Term Care

Today’s StayAlert! Notice reviews the new Human Resource requirements that TJC has published for Fluoroscopy and CT services. As StayAlert!...

Sources:
  • The Joint Commission
Relevant To:
  • Critical Access Hospitals,
  • Hospitals,
  • Ambulatory Care,
  • Clinical Lab